Acro Biomedical Co Ltd: A Steady Presence in the Nutritional Health Sector

In the ever-evolving landscape of the health care industry, Acro Biomedical Co Ltd has maintained a consistent presence, particularly in the niche market of nutritional health products. As of July 21, 2025, the company’s stock price on the OTC Bulletin Board remains steady at $0.0007, reflecting both its 52-week high and low. This stability in stock price underscores a period of steady operations amidst a volatile market environment.

Acro Biomedical Co Ltd, formerly known as Killer Waves Hawaii, Inc., has carved out a unique position in the health care sector by focusing on the development and marketing of specialized nutritional products. The company’s product line includes cordycepin and cordyceps powder, derived from a fungus traditionally used in Chinese medicine, and metallothionein MT-3 Elizer, a protein powder that has gained traction in the health supplement market.

Despite a market capitalization of $42,030 USD and a negative price-to-earnings ratio of -0.002775, Acro Biomedical Co Ltd continues to focus on its core offerings. The company’s dedication to these specialized products highlights its commitment to leveraging traditional and innovative health solutions to meet consumer needs.

As Acro Biomedical Co Ltd navigates the complexities of the health care industry, its strategic focus on niche nutritional products positions it uniquely within the sector. The company’s ability to maintain a steady stock price amidst market fluctuations speaks to its resilience and potential for future growth.

For those interested in learning more about Acro Biomedical Co Ltd and its product offerings, further information is available on its website at www.acrobiomedicalco.com . As the company continues to evolve, it remains a noteworthy entity in the health care providers and services industry, particularly for those interested in the intersection of traditional medicine and modern nutritional science.